- Home
- EXP vs CORT Comparison
EXP vs CORT Comparison
Compare EXP & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXP | CORT |
|---|---|---|
| Founded | 1963 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 8.6B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | EXP | CORT |
|---|---|---|
| Price | $216.27 | $84.25 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $236.25 | $130.20 |
| AVG Volume (30 Days) | 442.9K | ★ 965.7K |
| Earning Date | 01-28-2026 | 11-04-2025 |
| Dividend Yield | ★ 0.46% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 13.52 | 0.87 |
| Revenue | ★ $2,301,796,000.00 | $741,172,000.00 |
| Revenue This Year | $2.81 | $23.79 |
| Revenue Next Year | $3.96 | $40.97 |
| P/E Ratio | ★ $16.09 | $95.90 |
| Revenue Growth | 1.50 | ★ 17.92 |
| 52 Week Low | $191.91 | $49.00 |
| 52 Week High | $265.42 | $117.33 |
Technical Indicators
Market Signals| Indicator | EXP | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 45.37 | 56.68 |
| Support Level | $215.30 | $78.07 |
| Resistance Level | $226.83 | $85.34 |
| Average True Range (ATR) | 5.65 | 3.45 |
| MACD | -0.40 | -0.25 |
| Stochastic Oscillator | 6.92 | 60.29 |
Price Performance
Historical ComparisonAbout EXP Eagle Materials Inc
Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.